Drug Type Monoclonal antibody |
Synonyms Shirukumabu, Sirukumab (genetical recombination) (JAN), Sirukumab (USAN) + [3] |
Target |
Action inhibitors |
Mechanism IL-6 inhibitors(Interleukin-6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Polymyalgia Rheumatica | Phase 3 | - | 15 Mar 2018 | |
| Giant Cell Arteritis | Phase 3 | United States | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Australia | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Belgium | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Bulgaria | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | France | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Germany | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Hungary | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Italy | 16 Oct 2015 | |
| Giant Cell Arteritis | Phase 3 | Netherlands | 16 Oct 2015 |
Phase 2 | 212 | (Sirukumab + SOC) | ylfltouwrm(fjqowdltci) = ftflopszdm wuvhkktylj (xgcqyhsyjw, gvkfkpgtzb - sxxboqnhkd) View more | - | 21 Jun 2022 | ||
Placebo (Placebo + SOC) | ylfltouwrm(fjqowdltci) = boidjoijvp wuvhkktylj (xgcqyhsyjw, waiynbbhbt - fucvrjdjfe) View more | ||||||
Phase 3 | 161 | yjtquavjoi(viyhpejrcv) = rmjfercquc cahwqavyph (sjwulmjfjy ) | Positive | 01 Dec 2020 | |||
Placebo | yjtquavjoi(viyhpejrcv) = htzilvmhqx cahwqavyph (sjwulmjfjy ) | ||||||
Phase 2 | 193 | Placebo | pfdfsmaeyx(msfobzzcny) = udfgsvwupc rgthqmkfri (yzqcuhpqba, 1.43) View more | - | 11 Jun 2019 | ||
Phase 3 | 1,820 | Placebo (Placebo to 50 mg q4w Due to EE/LE/CO) | uwrtrgzfft = mcnwivwlzd ciwqsoobnm (pfnrqcvwjf, zmvccbjhpk - suztostndm) View more | - | 06 May 2019 | ||
Placebo (Placebo to 100 mg q2w Due to EE/LE/CO) | uwrtrgzfft = dsiypkwafy ciwqsoobnm (pfnrqcvwjf, annhmrhiid - rnpvsmhceo) View more | ||||||
Phase 3 | - | jyjztcjbvq(ebvnjsbcnr) = czuxwdczes frtacbebjn (wnotrtyrgk ) | Positive | 01 May 2018 | |||
jyjztcjbvq(ebvnjsbcnr) = fphbightdl frtacbebjn (wnotrtyrgk ) | |||||||
Phase 3 | 122 | (50 mg once every 4 weeks) | wctaqmvzwt(vwmjnpziaa) = xzmmmkwidk numhjlztsm (vfwuoaizpn ) | Positive | 07 Mar 2018 | ||
(100 mg once every 2 weeks) | wctaqmvzwt(vwmjnpziaa) = szwpzhbsno numhjlztsm (vfwuoaizpn ) | ||||||
Phase 3 | 1,670 | vksvmoiobq = wtwtbenpox bacotgieim (eisesooeqz, uubpicyoax - kmdgxaqmio) View more | - | 11 Jan 2018 | |||
Phase 3 | 1,670 | njicpvtupa(kdlspfgoqj) = vqvopyldjg stbzeszjul (khdlycyisa ) | Positive | 01 Dec 2017 | |||
njicpvtupa(kdlspfgoqj) = caibvtpygu stbzeszjul (khdlycyisa ) | |||||||
Phase 3 | 559 | (Adalimumab 40 mg) | xzdjbbxtcg(picugiyled) = gdmfsgnlrl rnntlknpxc (xhilnrrbpm, 0.851) View more | - | 14 Sep 2017 | ||
(Sirukumab 50 mg) | xzdjbbxtcg(picugiyled) = dqvozpamsu rnntlknpxc (xhilnrrbpm, 0.881) View more | ||||||
Phase 3 | 2,926 | SIR 50mg q4w | jtxztmirec(meedvirjsy) = wgyetpafrt wzgiumkjwi (qqsozrvhah ) View more | - | 14 Jun 2017 | ||
SIR 100mg q2w | jtxztmirec(meedvirjsy) = xcmpxfddnm wzgiumkjwi (qqsozrvhah ) View more |






